Govt Job for M.Pharm, M.Sc at National Institute of Immunology
The National Institute of Immunology is committed to advanced research addressing the basic mechanisms involved in body’s defence to identify modalities for manipulation of the immune system to provide protection against diseases…
Investment in healthcare should not be considered as expenditure: Dr Soumya Swaminathan
Dr Soumya Swaminathan, chief scientist of the World Health Organisation (WHO), on Thursday said investment in the health care system should be looked at as investment and not as expenditure. Delivering a keynote…
We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly: WHO official on Covaxin EUL
By Yoshita Singh United Nations/Geneva, India’s Bharat Biotech has been submitting data on the EUL of Covaxin “regularly and very quickly” to a technical committee which hopes to have a final recommendation to…
Health Ministry Allows Import Of Oxytocin API To Manufacture Exclusively For The Purpose Of Exports
New Delhi, 29 Oct 2021: The Union health ministry has exempted import of active pharmaceutical ingredient (API) of peptide hormone oxytocin to the country for the purpose of manufacturing formulations exclusively…
Govt Job for B.Pharm at Pharmaceuticals & Medical Devices Bureau of India
Pharmaceuticals & Medical Devices Bureau of India (PMBI) is the implementing agency of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). PMBI was established in December, 2008 under the Department of Pharmaceuticals, Government…
Merck Agrees To Let Other Drug Makers Make Its COVID Pill
LONDON : Pharmaceutical company Merck agreed to allow other drug makers worldwide to produce its COVID-19 pill, in a move aimed at helping millions of people in poorer countries get…
WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend
The World Health Organisation on Wednesday said it expects to receive clarifications from Bharat Biotech by the end of this week on its COVID-19 vaccine — Covaxin — and will meet on November 3 for a final risk-benefit…
WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’
The World Health Organisation’s technical advisory group on Tuesday sought “additional clarifications” from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final “risk-benefit assessment” for Emergency Use Listing of the vaccine. Hyderabad-based Bharat Biotech,…
Govt Job for Pharmacists under National Urban Health Mission
Under National Health Mission, applications are invited for appointment on various posts on contract basis for various health institutions / district hospitals for Dhanbad district of Jharkhand. Post : Pharmacist (NUHM) No of…
NPPA fixes price caps for 12 anti-diabetic medicines
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) on Monday said it has fixed the ceiling prices for 12 anti-diabetic generic medicines, including glimepiride tablets, glucose injection and intermediate acting insulin solution. In…
